International Patent: USE OF ANTIGEN-BINDING MOLECULE HAVING SPECIFICITY FOR CD3 AND CD19 FOR TREATMENT OF REFRACTORY RHEUMATOID ARTHRITIS

GENEVA, Oct. 30 -- FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NÜRNBERG, IN VERTRETUNG DES FREISTAATES BAYERN filed a patent application (EP2026/061908) for “USE OF ANTIGEN-BINDING MOLECULE HAVING SPECIFICITY FOR CD3 AND CD19 FOR TREATMENT OF REFRACTORY RHEUMATOID ARTHRITIS”. With publication no. WO/2026/224365, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....